Dementia Symptom Management at Home Program
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03255967|
Recruitment Status : Recruiting
First Posted : August 21, 2017
Last Update Posted : June 7, 2018
|Condition or disease||Intervention/treatment||Phase|
|Dementia||Behavioral: DSM-H Behavioral: Standard of Care||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||300 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Multisite Cluster RCT of the Dementia Symptom Management at Home Program|
|Actual Study Start Date :||May 21, 2018|
|Estimated Primary Completion Date :||August 2021|
|Estimated Study Completion Date :||August 2021|
Experimental: QI program care
DSM-H performance improvement program Patients in the performance improvement group will receive care from a care team who has received the DSM-H performance improvement program
Multi-modal quality improvement program for improving the quality of care provided to PWD-informal caregiver dyads through HHC
Active Comparator: Control
provide usual carereceive usual care from a care team who has not received the performance improvement program
Behavioral: Standard of Care
Subjects receive care through usual home healthcare assignment process.
- Quality of Life-Alzheimer's Disease [ Time Frame: 60 Days ]The investigators will evaluate patient health-related quality of life (HRQOL) by proxy (caregiver) assessment using the 15-item Health Utilities Index (HUI2), a generic health state classification system with preference-based utility weights derived from the general population. The HUI is one of the more widely used utility measures and has been used in previous studies of elderly with dementia and their caregivers.
- Change in Caregiver-Targeted Quality of Life Measure [ Time Frame: 60 Days ]The Caregiver-Targeted Quality of Life (CG-QOL) measure covers 10 dimensions of QOL relevant to caregivers of persons with dementia, incorporates non-health related issues as well as positive aspects of caregiving, and has demonstrated feasibility as a phone-based instrument in both English and Spanish. Eighty items are distributed across 10 scales: assistance with ADLs, assistance with IADLs, personal time, role limitation due to caregiving, family involvement, demands of caregiving, worry, caregiver feelings, spirituality and faith, benefits of caregiving.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03255967
|Contact: Kimberly Convery||212 992 7341||Kimberly.Convery@nyumc.org|
|United States, New York|
|New York University School of Medicine||Recruiting|
|New York, New York, United States, 10016|
|Contact: Kimberly Convery 212-992-7341 Kimberly.Convery@nyumc.org|
|Principal Investigator: Abraham Brody, MD|
|Principal Investigator:||Abraham Brody, MD||New York University School of Medicine|